EDTA PROCEEDINGS

 

 

 

 

 

VOLUME 16

 

 

 

 

 

AMSTERDAM - 1979

 

 

 

 

 

 

 

 

 

 

INTRODUCTION

 

 

 

 

 

Cover [PDF]

 

 

 

 

 

Preface [PDF]

 

 

 

 

 

Contents [PDF]

 

 

 

 

 

Foreword [PDF]

 

 

 

 

 

Part I – STATISTICAL REPORTS

Page

 

 

 

 

Combined Report on Regular Dialysis and Transplantation in Europe, IX, 1978   [PDF]

1:73 

 

 

FP Brunner, H Brynger, C Chantler, RA Doncherwolche, RA Hatway, C Jacobs, N H Selwood, A J Wing

 

 

 

 

 

 

Combined Report on Regular Dialysis and Transplantation of Children in Europe, 1978   [PDF]

74:104

 

 

RA Doncherwolche, C Chantler, FP Brunner, H Brynger, RA Hatway, C Jacobs, NH Selwood, AJ Wing

 

 

       

Part II – DIALYSIS I

 

 

 

 

 

 

Effect of residual renal function on minimum dialysis requirements [PDF]

105:114

 

 

S Ahmad, A L Babb, J Milutinovic, B H Scribner

 

 

       

RDT with acetate-free bicarbonate buffered dialysis fluid: long-term effects on lipid pattern, acid-base balance and oxygen delivery [PDF]

115:121

 

 

G Giorcelli, F Dalmasso, M Bruno, S Pellegrino, M Tondolo, M Sirkka, G Vacha

 

 

       

The influence of acetate versus bicarbonate on patient symptomatology during dialysis[PDF]

122:128

 

 

K nagai, M Pagel, T Rattazzi, J Vizzo, B H Scribner

 

 

       

Intracellular free amino acids in patients treated with regular heamodialysis (HD) [PDF]

129:134

 

 

A Alvestrand, J Bergstrom, P Furst

 

 

       

Reduction of unfavourable effects of heparin with use of gabexate mesilate in dialysis[PDF]

135:140

 

 

N Matsui, S Nakagawa, T Sasaoka, M Suenaga, N Yoshiyama, J Takeuchi

 

 

 

 

 

Non-A non-B hepatitis: a new syndrome in uraemic patients [PDF]

141:147

 

 

M M Avram, D A Feinfeld, A C Gan

 

 

     

Haemodialysis in schizophrenia: A double blind study - preliminary report [PDF]

148:154

 

 

J-L Vanherweghem, P lonkowski, C Jadot, J Mendlewicz

 

 

     

Part III  -  DIALYSIS 2

 

 

 

 

 

 

Evaluation of the participation of parietal peritoneum in dialysis: phsycological, morphological and pharmacological data [PDF]

155:164

 

 

J Knapowski, E feder, M simon, M Zabel

 

 

 

 

 

 

Central and peripheral haemodynamics in longterm peritoneal dialysis patients [PDF]

165:170

 

 

R Schurig, G Gahl, M Schartl, H becker, M Kessel

 

 

 

 

 

 

Continuous ambulatory peritoneal dialysis (CAPD) in the treatment of end-stage failure [PDF]

171:177

 

 

N M Thomson, R G Walker, G Whiteside, D F Scott, R C Atkins

 

 

 

 

 

 

Nineteen month experience with continuous ambulatory peritoneal dialysis (CAPD) [PDF]

178:183

 

 

D G Oreopoulos, S Clayton, N Dombros, G Zellerman, A Katirtzoglou

 

 

       

Advantages of continuous ambulatory peritoneal dialysis to the diabetic with renal failure[PDF]

184:193

 

 

C T Flynn, J Hibbard, B Dohrman

 

 

       

Normalisation of growth hormone hypersecretion in uraemic diabetics and non-diabetics. Studies with artificial pancreas and artificial kidney [PDF]

194:197

 

 

A Prange Hansen, H E Hansen, H Orskov, R Nosadini, G Noy, K G M M Alberti

 

 

       

Part IV –DIALYSIS 3

 

 

 

 

 

 

Comparison of solute permeability and rejection characteristics of normal and high flux cellulose haemodilysis membranes [PDF]

198:204

 

 

E Klein, F F Holland, K Eberie

 

 

 

 

 

 

Intestinal recycling and substitution of haemofiltrate in dogs [PDF]

205:211

 

 

P Kramer, M trautmann, E Heuer, L Drobnik, D Matthael, H J Groene, J Rieger, H Holscher, C Langescheid, F Scheler

 

 

 

 

 

 

Removal of uraemic toxins by haemofiltration with different membranes. The benefit of regenereting haemofiltrate using a newly developed system [PDF]

212:217

 

 

S Jorstad, L C Smeby, T-E Wideroe, K J Berg

 

 

 

 

 

 

Haemofiltration - critical evaluation of clinical benefits [PDF]

218:224

 

 

H Schneider, E Sreicher, U Hovelborn, H A G Muller, U Spohr, H Schmidt-Gayk

 

 

       

Prostacyclin eliminates the bioincompatibility of charcoal haemoperfusion [PDF]

225:231

 

 

M J Weston, H F Woods, S Bunting, S Moncada, J R Vane

 

 

       

Influence of the plasticiser Di-2-ethylhexylphthalate on drug metabolising enzymes in the liver of uraemic rats [PDF]

232:237

 

 

H W leber, T Uviss, A Prenter

 

 

       

Part   V –DIALYSIS 4

 

 

 

 

 

 

Vasopressin response in haemodialysis patients [PDF]

238:243

 

 

E Nord, G M Danovitch

 

 

 

 

 

 

Angiocardiographic and haemodynamic studies in chronic haemodialysis patients with cardiomegaly [PDF]

244:251

 

 

H T Drueke, C Le Pailleur, M Sigal-Saglier, J Zingraff

 

 

 

 

 

 

Hormonal response to volume depletion in non-nephrectomised patients on regular haemodialysis [PDF]

252:260

 

 

M Hammer, S Dawids, M Bredgaard Sorensen, O Christensen, K Olgaard

 

 

 

 

 

 

The effect of haemodialysis and transplantation on autonomic neurophaty [PDF]

261:265

 

 

J A Wilson, T M Yahya, G R Giles, A M Davison

 

 

       

Two year sequential haemodynamic data on polytetrafluoroethylene (PTFE) grafts used for haemodialysis [PDF]

266:271

 

 

M Kaye, C Baird, B mcCloskey, G Oscar, M d'Avirro

 

 

       

Thermography: an alternative to angiography for vascular access survey in haemodialysis [PDF]

272:276

 

 

J P masselot, J P Adhemar, J Laederich, D Kleinknecht

 

 

       

Peritoneal dialysis: physiology, current applications and future directions [PDF]

277:285

 

 

K D Nolph

 

 

       

Membranes and haemodialysis [PDF]

286:294

 

 

R L Stephen, A Zelman, B H Scribner

 

 

 

 

 

 

Part   VI – TRANSPLANTATION 1

 

 

 

 

 

 

How can HLA matching improve kidney graft survival? [PDF]

295:304

 

 

J J van Rood, G G persijn, Q Lansbergen, B Cohen, A van Leeuwen, B A Bradley

 

 

 

 

 

 

Modification of the immune response

305:309

 

 

Part One: Cyclosporin A in clinical kidney grafting from cadaver donors [PDF]

 

 

  R Y Calne, D J G White, S Thiru, D B Evans, P Mcmaster, D C Dunn, G N Craddock, K Rolles    

 

 

 

 

 

Part Two: Specific suppression of rejection in renal transplantation [PDF]

310:317  

 

  P J Morris    
        

The use of linear models to investigate the "centre effect" on graft survival [PDF]

318:325

 

 

R W Morris

 

 

 

 

 

 

A study of paired necro kidney grafts [PDF]

326:331
 

 

Lars U Lamm, Scandiatransplant and EDTA Registration Committee    
       

Orthopedic complications of renal transplantation [PDF]

332:338
 

 

J Nixon, S Hughes, J Castro    
       

The evolution of hyperlipidaemia late after renal transplantation [PDF]

339:346
 

 

M L Nicholas, G P J Alexandre, C van Ypersele de Strihou    
       

Cadaveric kidney retransplantation, is it justified? [PDF]

347:351
 

 

M J H Sloof, A M Tegzess, V J Filder, J M v.d. Voort-Beelen, R A F Krom, S Maijer, G Kootstra    
       

Is it really worth re-transplanting patient? [PDF]

352:358
 

 

A Marni, P McMaster, D B Evans, R Y Calne    
       

PART VII – TRANSPLANTATION 2

 

 

 

 

 

 

Cadaveric graft survival, clinical course, blood transfusions, HLA (A and B) match, and DR match in adult patients transplanted in one centre  [PDF]

359:365

 

 

J P van Hooff, A van Es, G G Peersijn, I J E A van Hooff-Eykenboom, M W Kaiff, J J van Rood, J de Graeff

 

 

 

 

 

 

Prolongation of renal allograft survival in DLA-tissue typed beagles after third-party leucocyte and erythrocyte transfusion [PDF]

366:371

 

 

H Obertop, A B bijnen, R H Schreve, D L Westbroek

 

 

 

 

 

 

Anti-HLA immunisation in 130 haemodialysed patients [PDF]

372:376

 

 

M Olmer, J Gaultier, P Mercier, M Rampal

 

 

 

 

 

 

Influence of the Lewis blood group system on clinical kidney transplantation [PDF]

377:382

 

 

Elisabeth Fischer, V Lenhard, W Romer, K Dreikorn, K Scharer, D Roelcke

 

 

 

 

 

 

PART VIII – TRANSPLANTATION 3

 

 

 

 

 

 

Use of thermography in kidney transplantation: two year follow up study in 75 cases [PDF]

383:387

 

 

H Kapsa, W Czech, P Schmidt, J Zazgornik, P Pils, P Balcke

 

 

 

 

 

 

Cadaveric renal graft acceptance without azathioprine [PDF]

388:394

 

 

P Schmidt, H Kopsa, P Balcke, J Zazgornick, P. Pils

 

 

 

 

 

 

Low dose steroid from the day following renal transplantation [PDF]

395:400

 

 

mary G McGeown, J F Douglas, W A Brown, R A Donaldson, J A Kennedy, W G Loughridge, S Mehta, Claire M Hill

 

 

 

 

 

 

Factors responsible for the functional pattern of cadaveric kidneys [PDF]

401:406

 

 

W Rowinski, L Gradowska, D Rowinska, M Lao, J Walaszewski, J Szmidt, J Nielubowicz, T Orlowski

 

 

 

 

 

 

The effect of transplantation on dialysis dementia [PDF]

407:412

 

 

A M davison, G R Giles

 

 

       

Foetal Liver transplant in fabry's disease [PDF]

413:425

 

 

M C Malik, J L Touraine, H Perrot, J Traeger

 

 

 

 

 

 

PART IX – TRANSPLANTATION 4

 

 

 

 

 

 

Pretransplant cytotoxic antibodies do not segregate kidney transplant recipients into responder and non-responder groups [PDF]

419:425

 

  F Vincenti, W Amend, N Fediska, R Duca, O Salvatierra

 

 

 

 

 

 

Human gamma globulin enhances the survival of renal allografts [PDF]

426:430

 

 

R R Riggio, J S Cheigh, M Suthanthiran, W T Stbenbord, M Fotino, R H Haschmeyer, K H Stenzel, A L Rubin

 

 

 

 

 

 

Endothelial antobodies in renal transplantation [PDF]

431:436

 

 

L C Paul, L A van Es, F H J Class, M W Kaliff

 

 

 

 

 

 

Detection of memory cells by chemical modification of the lymphocyte cell surface [PDF]

437:441

 

 

K H Stenzel, M Suthanthiran, A L Rubin, A Novogrodsky

 

 

 

 

 

 

Donor specific suppressor cells in association with rejection of a renal allograft [PDF]

442:448

 

 

J B Dossetor, E M Liburd, T Kovithavongs, M R Higgins, V Pazdkera

 

 

 

 

 

 

Pretransplant T [PDF]

449:453

 

 

J B Dossetor, E M Liburd, T Kovithavongs, M R Higgins, V Pazdkera

 

 

       

PART X –NEPHROLOGY 2

 

 

 

 

 

Prospects for prevention of chronic renal failure. Chrinic pyelonephritis [PDF]

454:466 

 

 

D N S Kerr, T Chochilas, H U Rashid

 

 

 

 

 

Prospects for prevention of chronic renal failure (continued). Prevention of renal disease[PDF]

466:474

 

 

U Bengtsson

 

 

 

 

 

Plasma inhibitors of the erythrocyte hexose monophosphate shunt in uraemia [PDF]

475:480

 

 

J Zingraff, P kamoun, P lebreton, T Drueke, N K Man, P Jungers

 

 

 

 

 

Are erythropoietin levels in uraemic patients on haemodialysis dependent on the kidney disease and the duration of haemodialysis treatment? [PDF]

481:486

 

 

A J Walle, W Niedermayer

 

 

 

 

 

Platelet hypersensitivity in the nephrotic syndrome [PDF]

487:494

 

 

G remuzzi, D marchesi, G Mecca, G de Gaetano, M Silver

 

 

 

 

 

Recovery of kidney function following prolonged acute renal failure [PDF]

495:499

 

 

H Kopsa, P Schmidt, J Zazgornik, P Pils, P Balcke

 

 

       

Treatment of renal amyloidosis with dimethylsulphoxide (DMSO) [PDF]

500:505

 

 

M H van Rijswijk, A J Donker, LRuinen, J Marrink

 

 

       

Postprandial serum creatinine increase in normal subjects after eating cooked meat [PDF]

506:512

 

 

F K Jacobson, C K Christensen, C E Mogensen, F Andreasen, N S C Heilskov

 

 

       
PART XI – NEPHROLOGY 2    
     

Evidence of high plymeric IgA levels in serum of patients with Berger's disease and its modification with phenytoin treatment [PDF]

513:519

 

 

M Lopes Trascasa, J Egido, J Sancho, L Hernando

 

 

 

 

 

Plasma exchange in immune complex disease [PDF]

520:527

 

 

D A Houwert, L kater, R J henè, A Struyvenberg

 

 

     

Plasma separation in Goodpasture's syndrome and multiple myeloma [PDF]

528:534

 

 

H G Sieberth, W Gloeckner, H Borberg, J Fohlmeister

 

 

     

Pathogenetic role of mesangial immune deposits [PDF]

535:541

 

 

S R Batsford, H Takamiya, R Rohrbach, A Vogt

 

 

     

Renal reflux, scarring, cystometrography and tissue types [PDF]

542:550

 

 

V Parsons, K W Munson, P Thompson, D Packham, L Kennedy

 

 

       

HLA Bw35 antigen and mesangial IgA glomerulonephritis: a poor prognosis marker? [PDF]

551:555

 

 

F C berthoux, C Genin, A Gagne, J C le Petit, J C Sabatier

 

 

     

PART XII – NEPHROLOGY 3

 

 

 

 

 

Urinary tract stone disease

[PDF]

556:565

 

 

M Peacook, W G Robertson, P J Heyburn, A Rutherford

 

 

 

 

 

Oxalic acid concentration in serum measured by isotopic clearance technique. Experience in hyper and normo-oxaluric subjects [PDF]

556:570

 

 

J A C Prenen, E J Dorhout mees, P Boer, H J Endeman, K H Ephraim

 

 

 

 

 

Thiazide diuretics in renal hypercalciuria [PDF]

571:576

 

 

A Aroldi, G Grazieni, G Mioni, M Cecchettin, D Brancaccio, C Galmozzi, M Surian, A Cantaluppi, C Ponticelli

 

 

     
PART XIII – NEPHROLOGY 4    

 

 

 

Production and action of a natriuretic hormone in isolated rat kidneys necessity of protglandins for its release [PDF]

577:582

 

 

P Cambier, J P Godon

 

 

 

 

 

Peptide hormones: renal handling and dialysis therapy [PDF]

583:587

 

 

E Schattler, H-J Schurek, K Schindhelm, R Zich, H Stolte

 

 

     

Evidence for aluminium accumulation in renal failure [PDF]

588:596

 

 

S N E Marsden, I S Parkinson, M K Ward, H A Ellis, D N S Kerr

 

 

     

Low molecular weight proteins as urinary markers of aminoglycoside nephrotoxicity in man [PDF]

597:602

 

 

J P Valette, G Nicot, J P Charmes, L Merle, D Benevent, C Leroux-Robert

 

 

     

Treatment of moderate to severe hypertensive patients with an orally active converting-enzyme inhibitor [PDF]

603:609

 

 

E J L Prins, A J M Donker, S J Hoorntje, F H H Leenen, G K van der Hem

 

 

     

Captopril and salt subtraction to treat "uncontrollable" hypertension in haemodialysis patients [PDF]

610:617

 

 

J P Wauters, B Waeber, H R Brunner, G A Turini, J P Guignars, H Gavras

 

 

       
PART XIV – NEPHROLOGY 5    
     

Pathogenesis of hypophosphataemia in kidney necrograft recipients: a controlled trial [PDF]

618:623

 

 

S Madsen, K Olgaard, Bi Lund, Bj Lund, O H Soerensen

 

 

     

handling of phosphate by the transplanted kideney [PDF]

624:629

 

 

H Graf, J Kovarik, H K Stummvoll, A Wolf, W F Pinggera

 

 

     

The relationship between disturbed metabolism of vitamine D and bone disease in chronic renal failure [PDF]

630:636

 

 

J A kanis, R G G Russell, C M Taylor, T Cundy, A Andrade, G Heynen

 

 

     

Renal osteopenia - an assesment of long-term therapy with vitamin D analogues [PDF]

637:643

 

 

G R D Catto, B J R Junor, R A Fraser, F W Smith, K V Ettinger, N Edward, M MacLeod

 

 

     

Renal bone disorders in children: Therapy with vitamin D3 or 1,25-dihydroxycholecalciferol [PDF]

644:648

 

 

M Bulla, G Delling, G Offermann, R Ziegler, G benz, H Luhmann, A Sanchez de Reutter, M Severin

 

 

     

Acute effects propranolol and metoprolol on plasma concentrations of parathyroid hormone and calcitonin in uraemic patients [PDF]

649:658

 

 

B Coevoet, C Desplan, J L Sebert, R Makdassi, J D Gherbrand, M Tolani, C Calmette, M S Moukhtar, A Fournier

 

 

     
PART XV – POSTERS    
     

A new approch to the early detection of dialysis encephalopathy

[PDF]

659:660

 

 

P Ackrill, J Barron, S Whiteley, A C Horn, A J Raitson

 

 

     

Prolactin, zinc and sexual activity in dialysis patients

[PDF]

661:662

 

 

C Campieri, A Ben dardeff, L C Borgnino, R Prandini, G Orsoni, S Stefani

 

 

     

Aluminium, EEG and intellectual function in patients on regular dialysis treatment ( RDT) [PDF]

663:664

 

 

P Gilli, P De Bastiani, F Fagioli, G Rosati, A Betti, A Farinelli

 

 

     

Study of trace elements in patients with chronic renal failure by neutron activation analysis [PDF]

665:667

 

 

Y Tsukamoto, S Iwanami, F Marumo

 

 

     

Propranolol and uraemic osteodystrophy [PDF]

668:671

 

 

D Brancaccio, C Galmocci, S Casati, D Rurale, Belloli, A Aroldi, G Graziani, C Ponticelli

 

 

     

Use of radioisotope technique Photon absorptiometry to defect early avascular necrosis

[PDF]

672:674

 

 

S N Chatterjee, J M Vogel, N Telfer

 

 

     

Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis

[PDF]

675:676

 

 

J F de Fremont, J L Sebert, J Gueris, P Marie, B Coevoet, R Makdassi, G Lambrey, P Metunier, A Fournier

 

 

     

Post-transplant hyperparathyroidism: retained control by serum Ca ++

[PDF]

677:678

 

 

D A McCarron, S Krutzik, J M Barry, R S Muther, W M Bennett

 

 

     

Vasodepressive effect pf parathyroid hormone in post-transplant blood pressure regulation

[PDF]

679:680

 

 

D A McCarron, S Krutik, J M barry, R S Muther, S Plant, W M Bennett

 

 

     

Protective effects of duretics in gentamicin nephrotoxicity

[PDF]

681:682

 

 

J Petersen, P H Whiting, J G Simpson

 

 

     

Haemodialysis in schizophrenia

[PDF]

683:685

 

 

G Splendiani, V Bruno, F De Meo, F Feriozzi, M Cammà, P Pomero

 

 

     

Haemodynamic dangers of high flow arterio-venous fistulas

[PDF]

686:687

 

 

L Burrows, K Kwun, H Schanzer, M Haimov

 

 

     

Phatophysiology of exaggerated natiuresis of hypertension

[PDF]

688:689

 

 

A Dal Canton, G Conte, G Fuiano, R Guasco, V E Andreaucci

 

 

       

Arteriovenous fistula (AVF) blood flow in chronic haemodialysis patients (CHP): comparison of results obtained by the dye-dilution method (QAVF) and by variation in cardiac output during temporary occlusion of the AVF

[PDF]

690:691

 

 

G Dongradi, P Rocha, J C Kahn, B Baron, P Marichez, J P Fendler

 

 

       

Cardiothoracic ratio as an index of body fluid balance in patients receiving RDT

[PDF]

692:694

 

 

A Poggi, Q Maggiore

 

 

       

Vascular stability during high flux haemofiltration (HF)

[PDF]

695:697

 

 

S Shaldon, G Deschodt, M C Beau, G Claret, H Mion, G Mion

 

 

       

Glucose tolerance in patients on haemodialysis, sequential ultrafiltration and dialysis and haemofiltration

[PDF]

698:699

 

 

R Geronemus, B von Albertini, S Glabman, T Khan, E Rayfield, J P Bosch

 

 

       

Prolactin in chronic renal failure, haemodialysis, and transplant patients

[PDF]

700:702

 

 

R Peces, S Casado, M Frutos, C Horcajada, J M Lopez-Novoa, L Hernando

 

 

       

Prolactin, growth hormone, thyrotropin, insulin, C-peptide, glucose, tolerance and pituitary-gonadal axis in patients with compensated renal failure

[PDF]

703:705

 

 

G Schernthaner, H K Stummevoll, H Ludvig, J Spona

 

 

       

Heymann nephritis of rats: ia a vasopermeability mechanism really needed for immune complex deposition?

[PDF]

706:708

 

 

F Alonso, J Egido, M Sanchez Crespo, L Hernando

 

 

       

Are circulating immune complexes and complemet breakdown products useful for the detection of disease activity in nephrology?

[PDF]

709:710

 

 

R Coppo, F Giacchino, S Alloatti, F Quarello, G Segoloni, P Bossi, A Vercellone, G Piccoli

 

 

       

Mitogen-induced lymphocyte transformation during haemodialysis

[PDF]

711:713

 

 

H Ludwig, H K Stummvoll, G Schernthaner

 

 

       

Lymphocyte markers and circulating immune complexes in primary glomerulonephritis

[PDF]

714:716

 

 

P L Meroni, P Dall'Aglio, G Balestrieri, L Allegri, G F Cibodda, G Colombo, A Tincani

 

 

       

Oxalate removal by dialysis and haemoperfusion

[PDF]

717:718

 

 

Q Maggiore, A Poggi, S Parlongo, T Cerrai

 

 

       

Plasma keto-analogues in uraemia patients

[PDF]

719:720

 

 

D Matthaei, P Schauder, P Kramer, K Grieben, F Scheler, A Mench-Hoinowski, U Langenbeck

 

 

       

Urinary megnesium excretion in different types of hypercalciuria with recurrent calcareus nephrolithiasis

[PDF]

721:722

 

 

L Minetti, G Colussi, A Antonacci, A Aroldi, G Graziani, M Surian

 

 

       

Effect of haemofiltration (HF) and haemodialysis (HD) on erythrocyte organic phosphates in uraemic patients

[PDF]

723:724

 

 

D E Muller-Wiefel, B Klare, K Scharer

 

 

       

Serum trypsin concentration in renal disease

[PDF]

725:726

 

 

K W Rumpf, H Koop, F Stockmann, P G lankisch, F Scheler

 

 

       

Pyridoxine therapy of adult primary oxalosis

[PDF]

727:728

 

 

E J Will, O L M Bijvoet

 

 

       

Neurophaty and short time haemodialysis (STH)

[PDF]

729:730

 

 

U Graefe, D Steinhausen, K Langer, G Alterhoff, O Knoll, H Loew

 

 

       

Treatment of uraemic peripheral neuritis by direct haemoperfusion with activated charcoal

[PDF]

731:732

 

 

O Otsubo, K kuzuhara, Y Sinada, Y Yamauchi, J Takahashi, Y Yamada, K Otsubo, T Inou

 

 

       

A new sterile connecting system to avoid peritonitis in continuous ambulatory peritoneal dialysis

[PDF]

733:734

 

 

H Becker, R Schurig, K Affed, A Mohnhaupt, F Zartnack, J Frank

 

 

       

Peritoneal dialysis in ketosos-susceptible diabetes mellitus

[PDF]

735:736

 

 

C Kablitz, R L Stephen, D P Duffy, W J Kolff

 

 

       

Value of biochemical measurements on the residual peritoneal fluid in patients on chronic intermittent peritoneal dialysis

[PDF]

737:738

 

 

G Lambrey, B Coevoet, J F de Fremont, J M Hardin, A Fournier

 

 

       

The migration of plasticisers from PVC haemodialysis tubes

[PDF]

739:740

 

 

J Gerstof, E Christiansen, J L Nielsen, B Nielsen

 

 

       

Long term observation of dermatological findings in renal transplant recipients

[PDF]

741:742

 

 

H Kopsa, P Schmidt, J Zazgormik, P Pils, P Balcke, J Thurner

 

 

       

Ultraviolet phototherapy in uraemic pruritus

[PDF]

743:744

 

 

N B Simpson, A M Davison

 

 

       

Cellular immunity in herpes simplex and cytomegalovirus infections in renal allograft recipients

[PDF]

745:746

 

 

E Spencer, A Moeller-Larsen, H K Andersen, S Haahr

 

 

       

Selecting the programme for EDTA

[PDF]

747:752

 

 

D N S Kerr, V Andreucci, J Bergstrom, S T Boen, V Cambi, L E Gelin, B kock, F Kokot, M Legrain, B H B Robinson, G Schutterle, A Struyvenberg, A Valek

 

 

       
     

Membership of the European Dialysis and Transplant Association

[PDF]

753:754

 

 

 

 

 

Subject Index

[PDF]

755:772

 

     
     

 

In order to open the above PDF files you need Acrobat Reader.

If you do not have it, you can download it here